MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors

by Brian Shuch, Ryan Falbo, Fabio Parisi, Adebowale Adeniran, Yuval Kluger, Harriet M. Kluger, Lucia B. Jilaveanu
Published 2015-01-01

Perilesional edema in brain metastases: potential causes and implications for treatment with immune therapy

by Thuy T. Tran, Amit Mahajan, Veronica L. Chiang, Sarah B. Goldberg, Don X. Nguyen, Lucia B. Jilaveanu, Harriet M. Kluger
Published 2019-07-01

Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cells.

by Christopher R Zito, Lucia B Jilaveanu, Valsamo Anagnostou, David Rimm, Gerold Bepler, Sauveur-Michel Maira, Wolfgang Hackl, Robert Camp, Harriet M Kluger, Herta H Chao
Published 2012-01-01

On the Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) in Human Malignancies

by Andreea Calinescu, Gabriela Turcu, Roxana I. Nedelcu, Alice Brinzea, Anastasia Hodorogea, Mihaela Antohe, Carmen Diaconu, Coralia Bleotu, Daniel Pirici, Lucia B. Jilaveanu, Daniela A. Ion, Ioana A. Badarau
Published 2018-01-01

Expression of drug targets in patients treated with sorafenib, carboplatin and paclitaxel.

by Lucia B Jilaveanu, Fengmin Zhao, Christopher R Zito, John M Kirkwood, Katherine L Nathanson, Kurt D'Andrea, Melissa Wilson, David L Rimm, Keith T Flaherty, Sandra J Lee, Harriet M Kluger
Published 2013-01-01

Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune Cells

by Thuy T. Tran, Chetan K. Rane, Christopher R. Zito, Sarah A. Weiss, Shlomit Jessel, Liliana Lucca, Benjamin Y. Lu, Victor O. Oria, Adebowale Adeniran, Veronica L. Chiang, Sacit Bulent Omay, David A. Hafler, Harriet M. Kluger, Lucia B. Jilaveanu
Published 2021-03-01